Tobias Gustavsson

Tobias Gustavsson is an Associate Professor in the Department of Immunology and Microbiology at the University of Copenhagen's Faculty of Health and Medical Sciences. His research focuses on innovative approaches to cancer detection and treatment through glycobiology, particularly targeting oncofetal chondroitin sulfate.

His primary research interests include Cancer Immunology, Glycobiology, Vaccine Development, Tumor Microenvironment studies, Circulating Tumor Cell analysis, CAR T Cell Therapy, and Extracellular Vesicle research. His work bridges the gap between fundamental glycobiology and clinical applications, with a particular emphasis on developing tumor-agnostic diagnostic and therapeutic approaches.

Analysis of his recent publications reveals a strong focus on translating basic glycobiology discoveries into clinical applications. His research demonstrates how malaria proteins like VAR2CSA can be repurposed for cancer detection, how oncofetal chondroitin sulfate serves as a universal cancer biomarker, and how these discoveries can be leveraged for novel therapeutic approaches including CAR T cells and antibody-based treatments.

His scientific contributions have been recognized through publications in high-impact journals including Nature Nanotechnology, Nature Communications, and Cell Reports Medicine, with several papers receiving significant media attention and social media discussion.

Dr. Gustavsson actively collaborates with numerous researchers across the University of Copenhagen and internationally, particularly with the Salanti and Theander research groups, focusing on translating glycobiology discoveries into clinical applications for cancer diagnosis and treatment.